Zirconium metal-organic framework-based composite drug delivery system for precise drug release and synergistic modulation of the tumor microenvironment in liver cancer therapy
Acta Biomaterialia · 2026-10 · 223 · 562-576
DOI: 10.1016/j.actbio.2026.09.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-10. Verfasst von Yujia Han und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Petrochemical Technology, Lanzhou University of Technology, Lanzhou, 730050, China. Hauptthemen laut MEDLINE: Zirconium, Tumor Microenvironment, Liver Neoplasms, Metal-Organic Frameworks. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Innovation and Entrepreneurship Talent Project of Lanzhou, Lanzhou University of Technology, National Natural Science Foundation of China.
Abstract (Originalsprache)
Zirconium-based metal-organic framework (MOF-808) materials were selected as drug delivery carriers, with 5-fluorouracil (5-Flu) as the model drug. MOF-808@5-Flu drug-loaded carriers were designed and prepared at different ratios. The drug release behavior of the MOF-808@5-Flu nanocomposite was investigated under different pH conditions (7.4/6.5/5.0). The results showed that when the mass ratio of MOF-808 to 5-Flu was 1:0.25, the material released 55.56% of the drug within 50 h at pH 5.0, compared with 47.85% and 48.00% at pH 7.4 and 6.5, respectively. The drug release behavior was well fitted by the Higuchi model the Higuchi model. Cell and animal experiments demonstrated that MOF-808@5-Flu exhibited good biocompatibility and significantly inhibited the growth of Hepa1-6 cells, indicating its potential as a targeted nanocarrier to enhance therapeutic efficacy. Studies indicate that MOF-808@5-Flu induces cancer cell death through the apoptotic pathway. The catalytic activity of Zr4+ acted synergistically with the pharmacological effects of 5-Flu, generated a large amount of reactive oxygen species (ROS), significantly reducing tumor cell viability. Theoretical calculations indicated that MOF-808@5-Flu exhibits synergistic effects through multiple interactions, including π-π stacking, electrostatic attraction, and hydrophobic interactions. This results further highlights the advantages of MOF-808@5-Flu as a drug delivery platform. In summary, MOF-808@5-Flu shows great potential as a targeted nanocarrier for anticancer drug delivery. STATEMENT OF SIGNIFICANCE: Developed MOF-808@5-Flu nanocarriers with strong potential for targeted anticancer drug delivery. Achieved pH-responsive 5-Flu release, with the highest release rate of 55.56% at pH 5.0 within 50 h. Confirmed that the drug release profile follows the Higuchi model. Demonstrated good biocompatibility and effective inhibition of Hepa1-6 tumor cell growth. Revealed a "carrier-drug" synergistic mechanism driven by Zr4+ catalysis and multiple intermolecular interactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Petrochemical Technology, Lanzhou University of Technology, Lanzhou, 730050, China.
- Ophthalmologic, The First People's Hospital of Lanzhou City, Lanzhou 730050, China.
- School of Petrochemical Technology, Lanzhou University of Technology, Lanzhou, 730050, China. Electronic address: wangkj80@163.com.
Förderung
- Innovation and Entrepreneurship Talent Project of Lanzhou
- Lanzhou University of Technology
- National Natural Science Foundation of China
- Gansu Provincial Natural Science Foundation
Zitieren
APA
Han, Y., Zeng, H., Xu, J., Hao, H., Li, H., Niu, X., Li, Y., Liu, X., Zhang, D., Chen, L., Zhang, D., & Wang, K. (2026). Zirconium metal-organic framework-based composite drug delivery system for precise drug release and synergistic modulation of the tumor microenvironment in liver cancer therapy. Acta Biomaterialia, 223, 562-576. https://doi.org/10.1016/j.actbio.2026.09.006
Vancouver
Han Y, Zeng H, Xu J, Hao H, Li H, Niu X, et al. Zirconium metal-organic framework-based composite drug delivery system for precise drug release and synergistic modulation of the tumor microenvironment in liver cancer therapy. Acta Biomaterialia. 2026;223:562-576. doi:10.1016/j.actbio.2026.09.006
BibTeX
@article{Han2026,
author = {Han, Yujia and Zeng, Haixiang and Xu, Jing and Hao, Hongyan and Li, Hongxia and Niu, Xiaohui and Li, Yan and Liu, Xiaoyu and Zhang, Deyi and Chen, Li and Zhang, Dongqiang and Wang, Kunjie},
title = {Zirconium metal-organic framework-based composite drug delivery system for precise drug release and synergistic modulation of the tumor microenvironment in liver cancer therapy},
journal = {Acta Biomaterialia},
year = {2026},
volume = {223},
pages = {562--576},
doi = {10.1016/j.actbio.2026.09.006}
}
EUVIMED